KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Precigen (PGEN) EBIT (2016 - 2026)

Precigen has reported EBIT over the past 14 years, most recently at -$21.7 million for Q4 2025.

  • Quarterly EBIT rose 24.02% to -$21.7 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$110.5 million through Dec 2025, up 18.16% year-over-year, with the annual reading at -$110.5 million for FY2025, 18.16% up from the prior year.
  • EBIT was -$21.7 million for Q4 2025 at Precigen, up from -$34.5 million in the prior quarter.
  • Over five years, EBIT peaked at -$7.6 million in Q3 2022 and troughed at -$60.8 million in Q2 2024.
  • The 5-year median for EBIT is -$22.4 million (2022), against an average of -$25.4 million.
  • Year-over-year, EBIT skyrocketed 64.64% in 2022 and then tumbled 188.07% in 2024.
  • A 5-year view of EBIT shows it stood at -$21.9 million in 2021, then increased by 0.34% to -$21.8 million in 2022, then crashed by 57.01% to -$34.2 million in 2023, then increased by 16.68% to -$28.5 million in 2024, then grew by 24.02% to -$21.7 million in 2025.
  • Per Business Quant, the three most recent readings for PGEN's EBIT are -$21.7 million (Q4 2025), -$34.5 million (Q3 2025), and -$31.8 million (Q2 2025).